UPDATE: Brookline Capital Markets Upgrades Intellia Therapeutics (NTLA) to Buy

March 7, 2022 6:38 AM EST Send to a Friend
(Updated - March 7, 2022 6:38 AM EST)

Brookline Capital Markets analyst Leah RUsh Cann upgraded Intellia Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login